Targeted RNA-sequencing assays: a step forward compared to FISH and IHC techniques?

Cancer Med · 2019 · PMC6912030 · PMID 31651105

Europe PMC DOI

hedged sentences

0.3400

closest p · 6.8× alpha

0.3400

boldest claim

The sentences

did not reach statistical significanceP = .34not close (p > 0.1)

Rare variants, with median overall survival of 66.6 months, appeared to be of better prognosis than common variants, namely variants 1 and 3, with median OS of 17.6 months, although these results did not reach statistical significance ( P = .34) due to the reduced size of the cohort (Figure S2 ).

also in 111,027 other papers

a clear trendno p-value reported

Although not significant, there was a clear trend toward longer OS and PFS for patients with rare EML4‐ALK variants.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.